All In MedTech

Device Trial Radar · NCT06136312

Clinical Investigation of the Multi4 System

A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients With Suspected Recurrent Bladder Cancer Lesions

Last checked: Nov 20, 2026Latest source record: Apr 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

18

Actual

Start

Dec 1, 2023

Primary completion

Apr 2, 2025

Study completion Apr 2, 2025

Sponsor

Lead sponsor
Multi4 Medical AbNot on our public-company list
Sponsor type
Industry
Collaborators
Key2Compliance
First posted
Nov 18, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients with Suspected Recurrent Bladder Cancer Lesions

Conditions

  • Bladder Cancer

Interventions

  • Multi4Device

    TURBT procedure performed with the Multi4 instrument in local anesthesia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluable biopsiesTime frame: At procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sahlgrenska University Hospital

    Gothenburg, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.